Ocular Drug Delivery Systems and Formulations
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 20 December 2025 | Viewed by 918
Special Issue Editor
2. Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Porto, Portugal
Interests: drug delivery systems; pharmaceutics; nanoparticles; cyclodextrins; ophtalmic formulations
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Efficient drug delivery to ocular tissues remains a challenge due to the eye’s unique anatomical and physiological barriers. These barriers limit drug absorption, bioavailability, and therapeutic efficacy. In response, recent advances in the development of nanoscale drug delivery systems and novel biomaterials have opened new possibilities for targeted and sustained ocular therapies.
Innovative formulations—such as nanoparticles, liposomes, dendrimers, hydrogels, in situ gelling systems, and biodegradable implants, among others—offer enhanced drug stability, controlled release, prolonged residence time, and the ability to overcome conventional delivery limitations. These strategies enhance the penetration of therapeutic agents through ocular tissues, improving the treatment of different ocular structures, minimizing systemic absorption, and reducing potential side effects.
This Special Issue provides a comprehensive overview of recent advances in ocular drug delivery, focusing on cutting-edge formulations and delivery systems that are designed to overcome various ocular barriers.
By emphasizing the synergy between material science, pharmaceutical technology, and ocular biology, this Special Issue aims to inform and inspire future research toward more effective and patient-friendly ocular therapeutics.
Dr. Victoria Díaz-Tomé
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ocular drug delivery
- ophthalmic formulations
- ophthalmic drug bioavailability
- ophthalmic hydrogels
- ophthalmic pharmaceutical nanotechnology
- ocular therapies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
